000			02086 a2200613 4500
005			20250513213507.0
264		0	_c20001120
008			200011s 0 0 eng d
022			_a0065-2776
024	7		_a10.1016/s0065-2776(00)75006-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aMelief, C J
245	0	0	_aStrategies for immunotherapy of cancer. _h[electronic resource]
260			_bAdvances in immunology _c2000
300			_a235-82 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdjuvants, Immunologic
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Neoplasm _xtherapeutic use
650	0	4	_aAntigen Presentation
650	0	4	_aAntigens, CD _xphysiology
650	0	4	_aAntigens, Neoplasm _ximmunology
650	0	4	_aApoptosis
650	0	4	_aCancer Vaccines _xtherapeutic use
650	0	4	_aCytokines _xgenetics
650	0	4	_aDisease Susceptibility
650	0	4	_aGenetic Therapy
650	0	4	_aHumans
650	0	4	_aImmune Tolerance
650	0	4	_aImmunity, Innate
650	0	4	_aImmunoglobulin Idiotypes _ximmunology
650	0	4	_aImmunologic Deficiency Syndromes _xcomplications
650	0	4	_aImmunotherapy _xmethods
650	0	4	_aImmunotherapy, Active
650	0	4	_aImmunotherapy, Adoptive
650	0	4	_aLymphocyte Cooperation
650	0	4	_aLymphocytes, Tumor-Infiltrating _ximmunology
650	0	4	_aMice
650	0	4	_aNeoplasm Proteins _ximmunology
650	0	4	_aNeoplasms _xetiology
650	0	4	_aNeoplasms, Experimental _ximmunology
650	0	4	_aOncogenic Viruses _ximmunology
650	0	4	_aReceptors, Tumor Necrosis Factor _xphysiology
650	0	4	_aT-Lymphocyte Subsets _ximmunology
650	0	4	_aTumor Virus Infections _ximmunology
700	1		_aToes, R E
700	1		_aMedema, J P
700	1		_avan der Burg, S H
700	1		_aOssendorp, F
700	1		_aOffringa, R
773	0		_tAdvances in immunology _gvol. 75 _gp. 235-82
856	4	0	_uhttps://doi.org/10.1016/s0065-2776(00)75006-1 _zAvailable from publisher's website
999			_c10829939 _d10829939